Merit Competitors
| MMSI Stock | USD 82.50 2.87 3.60% |
Merit Medical vs Bruker Correlation
Average diversification
The correlation between Merit Medical Systems and BRKR is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Merit Medical Systems and BRKR in the same portfolio, assuming nothing else is changed.
Moving against Merit Stock
The Merit Medical's current Return On Capital Employed is estimated to increase to 0.1, while Return On Tangible Assets are projected to decrease to 0.05. As of now, Merit Medical's Total Current Assets are increasing as compared to previous years. The Merit Medical's current Intangible Assets is estimated to increase to about 601.7 M, while Other Assets are projected to decrease to under 26.4 M.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Merit Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Merit Medical Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Merit Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Merit and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Merit Medical Systems does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Merit Stock performing well and Merit Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Merit Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TFX | 1.90 | (0.23) | 0.00 | (0.14) | 0.00 | 3.55 | 22.60 | |||
| BLCO | 1.38 | 0.07 | 0.05 | 0.13 | 1.52 | 3.17 | 10.35 | |||
| STVN | 2.29 | (0.86) | 0.00 | (0.27) | 0.00 | 4.69 | 15.63 | |||
| KRYS | 1.63 | 0.48 | 0.25 | (7.39) | 1.24 | 4.10 | 11.01 | |||
| TGTX | 1.90 | (0.33) | 0.00 | (5.16) | 0.00 | 3.96 | 11.58 | |||
| GKOS | 2.01 | 0.34 | 0.16 | 0.46 | 1.87 | 5.29 | 14.33 | |||
| ALKS | 1.69 | 0.15 | 0.07 | 0.21 | 2.04 | 3.82 | 10.92 | |||
| PTCT | 1.51 | 0.09 | 0.01 | 0.66 | 2.10 | 3.88 | 13.88 | |||
| TMDX | 2.41 | 0.11 | 0.03 | 0.23 | 2.44 | 5.74 | 21.24 | |||
| BRKR | 2.08 | 0.04 | 0.03 | 0.11 | 2.23 | 4.32 | 12.82 |
Cross Equities Net Income Analysis
Compare Merit Medical Systems and related stocks such as Teleflex Incorporated, Bausch Lomb Corp, and Stevanato Group SpA Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TFX | 13.3 M | 323.3 M | (190.1 M) | 150.9 M | 187.7 M | 244.9 M | 237.4 M | 152.5 M | 200.8 M | 461.5 M | 335.3 M | 485.4 M | 363.1 M | 356.3 M | 69.7 M | 80.1 M | 151.6 M |
| BLCO | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 298 M | (18 M) | 182 M | 6 M | (260 M) | (317 M) | (285.3 M) | (271 M) |
| STVN | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 78.5 M | 134.3 M | 142.8 M | 145.6 M | 117.8 M | 135.4 M | 120.7 M |
| KRYS | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (1.1 M) | (7.9 M) | (10.9 M) | (19.1 M) | (32.2 M) | (69.6 M) | (140 M) | 10.9 M | 89.2 M | 102.5 M | 107.7 M |
| TGTX | (3.6 M) | (853.1 K) | (18.1 M) | (20.5 M) | (55.8 M) | (62.9 M) | (78.3 M) | (118.5 M) | (173.5 M) | (172.9 M) | (279.4 M) | (348.1 M) | (223.8 M) | 12.7 M | 23.4 M | 21 M | 22.1 M |
| GKOS | (19.3 M) | (19.3 M) | (19.3 M) | (12.6 M) | (12.1 M) | (37.2 M) | 4.5 M | (92 K) | (13 M) | 15.4 M | (120.3 M) | (49.6 M) | (99.2 M) | (134.7 M) | (146.4 M) | (131.7 M) | (125.1 M) |
| ALKS | (40.1 M) | 25 M | 25 M | 17.6 M | (30.1 M) | (227.2 M) | (208.4 M) | (157.9 M) | (139.3 M) | (196.6 M) | (110.9 M) | (48.2 M) | (158.3 M) | 355.8 M | 367.1 M | 422.1 M | 443.2 M |
| PTCT | 30.9 M | 30.9 M | (26.2 M) | (51.6 M) | (93.8 M) | (170.4 M) | (142.1 M) | (79 M) | (128.1 M) | (251.6 M) | (438.2 M) | (523.9 M) | (559 M) | (626.6 M) | (363.3 M) | (327 M) | (343.3 M) |
| TMDX | (17.6 M) | (24.1 M) | (24.1 M) | (24.1 M) | (24.1 M) | (24.1 M) | (24.1 M) | (20.8 M) | (23.8 M) | (33.5 M) | (28.7 M) | (44.2 M) | (36.2 M) | (25 M) | 35.5 M | 40.8 M | 42.8 M |
| BRKR | (888 K) | 92.3 M | 77.5 M | 80.1 M | 56.7 M | 101.6 M | 153.6 M | 78.6 M | 179.7 M | 197.2 M | 157.8 M | 277.1 M | 296.6 M | 427.2 M | 113.1 M | 130.1 M | 104.3 M |
Merit Medical Systems and related stocks such as Teleflex Incorporated, Bausch Lomb Corp, and Stevanato Group SpA Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Merit Medical Systems financial statement analysis. It represents the amount of money remaining after all of Merit Medical Systems operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Merit Medical Competitive Analysis
The better you understand Merit Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Merit Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Merit Medical's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Merit Medical Competition Performance Charts
Five steps to successful analysis of Merit Medical Competition
Merit Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Merit Medical Systems in relation to its competition. Merit Medical's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Merit Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Merit Medical's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Merit Medical Systems, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Merit Medical position
In addition to having Merit Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Market Funds Thematic Idea Now
Money Market Funds
Funds or Etfs investing in various types of short-term (less than one year) fixed income instruments of high-quality and liquidity. The Money Market Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Market Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Merit Medical Correlation with its peers. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is there potential for Health Care Equipment & Supplies market expansion? Will Merit introduce new products? Factors like these will boost the valuation of Merit Medical. Expected growth trajectory for Merit significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.04) | Earnings Share 1.96 | Revenue Per Share | Quarterly Revenue Growth 0.13 | Return On Assets |
Investors evaluate Merit Medical Systems using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Merit Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Merit Medical's market price to deviate significantly from intrinsic value.
Understanding that Merit Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Merit Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Merit Medical's market price signifies the transaction level at which participants voluntarily complete trades.